Title : Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? The ALGOVIRC Project Group.

Pub. Date : 2000 Jan

PMID : 10613748






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 UNLABELLED: Randomized trials have shown the enhancement of efficacy with interferon alfa-2b and ribavirin (IFN-R) in comparison with interferon monotherapy (IFN) as first line treatment of chronic hepatitis C. Further definition of response based on disease, patient, and treatment characteristics is needed to determine the degree of benefit for the various patient subgroups. Ribavirin interferon alpha 1 Homo sapiens